Sagimet Biosciences Inc. (SGMT)
Pharmaceutical Preparations
Latest Price
$10.46
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
4.82
P/B Ratio
2.17
Institutional Ownership
91.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.58M | $50.0M | 12.38% | +5.78M | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.63M | $28.0M | 6.83% | -- | 2026-06-30 |
| Woodline Partners LP | 3.00M | $23.0M | 5.65% | +2.00M | 2026-06-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.93M | $22.0M | 5.51% | +2.89M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.57M | $19.0M | 4.83% | +1.47M | 2026-06-30 |
| BVF INC/IL | 2.50M | $19.0M | 4.71% | -- | 2026-06-30 |
| Caligan Partners LP | 2.50M | $19.0M | 4.71% | -- | 2026-06-30 |
| FEDERATED HERMES, INC. | 2.09M | $16.0M | 3.93% | +2.09M | 2026-06-30 |
| GREAT POINT PARTNERS LLC | 2.03M | $15.0M | 3.82% | -- | 2026-06-30 |
| STATE STREET CORP | 2.00M | $15.0M | 3.76% | +1.87M | 2026-06-30 |